Walleye Trading’s Accretive Health AH Stock Holding History

Walleye Trading’s Portfolio AH Stock Details AH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-100	Closed	-$1K	–	4283
2013 Q4	$1K	Buy	+100	New	+$861	﹤0.01%	3592

Other funds holding AH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JRP

Jasper Ridge Partners Menlo Park, California $4.69B AUM 31.34% 1-Year Est. Return

ICM

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

SCA

SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

Walleye Trading's AH Position: Q1 2014 in Review

Walleye Trading sold out of Accretive Health (AH) in Q1 2014, closing a stake of 1,451 shares — an estimated $13K sold.

Walleye Trading first reported a position in AH in Q4 2013 and held it in 1 quarter. The position peaked at $13K in Q4 2013. 66 funds tracked by Wall St. Rank hold AH as of Q1 2014.

Walleye Trading reported no remaining Accretive Health position as of Q1 2014 after selling out during the quarter.
Walleye Trading sold 1,451 Accretive Health shares in Q1 2014, an estimated $13K.
Walleye Trading first reported a position in Accretive Health in Q4 2013 and held it in 1 quarter.
Walleye Trading's Accretive Health position peaked at $13K in Q4 2013.
66 funds tracked by Wall St. Rank held Accretive Health as of Q1 2014.

Based on Walleye Trading's 13F filing for Q1 2014, filed 15 May 2014.